McKesson Corporation (NYSE:MCK) has been downgraded to Underperform in a statement by Credit Suisse Group AG earlier today.

Credit Suisse Group AG has downgraded McKesson Corporation (NYSE:MCK) to Underperform in a statement released on 11/23/2016.

On 3/1/2016, Mizuho Securities released a statement about McKesson Corporation (NYSE:MCK) upped the target price from $0.00 to $164.00 that suggested an upside of 0.05%.

Having a price of $141.33, McKesson Corporation (NYSE:MCK) traded 1.27% higher on the day. With the last stock price down -18.12% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.03% over the same period. MCK has recorded a 50-day average of $148.97 and a two hundred day average of $174.72. Trade Volume was down over the average, with 846,406 shares of MCK changing hands under the typical 2,673,810

Recent Performance Chart

McKesson Corporation has 52 week low of $114.53 and a 52 week high of $202.20 with a PE ratio of 17.15 and has a market capitalization of $0.

In addition to Credit Suisse Group AG reporting its stock price target, a total of 15 brokers have issued a research note on the company. The average stock price target is $195.93 with 4 brokers rating the stock a strong buy, 7 brokers rating the stock a buy, 7 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

Brief Synopsis On McKesson Corporation (NYSE:MCK)

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.